Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Six of seven peptides now stand recommended, building on yesterdays four for four on BPC-157, TB-500, MOTS-c, and KPV
dose-dependent GI adverse events (nausea, vomiting) similar to other amylin analogues Exposure: Dose-proportional increases in Cmax and AUC Gastric Effects: Dose-dependent slowing of gastric emptying confirmed via paracetamol absorption test Appetite Suppression: Reduced ad libitum food intake at doses 1.2 mg Clinical Significance: Established feasibility of once-weekly dosing and identified dose range for Phase 2 studies
Even in the metabolically compromised environment of diabetic animals, BPC-157 accelerated wound healing
Pneumonia Risk in COPD Patients Research shows that inhaled corticosteroids like Budesonide may increase the risk of pneumonia in people with COPD
BPC-157 is often discussed in post-surgical and injury-rehabilitation contexts due to its potential to promote angiogenesis, nerve repair and tissue regeneration
US$ 25.27
US$ 29.25
US$ 29.44
US$ 24.00
